Stille AB (STO:STIL)
185.50
-5.00 (-2.62%)
Mar 2, 2026, 5:21 PM CET
Stille AB Market Cap
Stille AB has a market cap or net worth of 1.71 billion as of March 2, 2026. Its market cap has decreased by -17.17% in one year.
Market Cap
1.71B
Enterprise Value
1.59B
Revenue
567.63M
Ranking
n/a
PE Ratio
30.73
Stock Price
185.50
Market Cap Chart
Since November 25, 2005, Stille AB's market cap has increased from 117.81M to 1.71B, an increase of 1,352.98%. That is a compound annual growth rate of 14.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.71B | -2.81% |
| Dec 30, 2025 | 1.76B | -5.77% |
| Dec 30, 2024 | 1.87B | 146.88% |
| Dec 29, 2023 | 757.04M | 34.82% |
| Dec 30, 2022 | 561.51M | -25.58% |
| Dec 30, 2021 | 754.53M | 69.88% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| Cereno Scientific AB | 1.98B |
| Egetis Therapeutics AB | 1.81B |
| EQL Pharma AB | 1.71B |
| Carasent AB | 1.65B |